Literature DB >> 35739425

Surgical management of endolymphatic sac tumor: classification, outcomes and strategy. A single institution's experience.

Nan Wu1,2,3,4, Xiaoyan Ma1,2,3,4,5, Weidong Shen1,2,3,4, Zhaohui Hou1,2,3,4, Weiju Han1,2,3,4, Pu Dai1,2,3,4, Hui Zhao1,2,3,4, Deliang Huang1,2,3,4, Dongyi Han6,7,8,9,10, Shiming Yang1,2,3,4.   

Abstract

PURPOSE: To review the resections of endolymphatic sac tumor (ELST) and describe our experience in the surgical management of ELST.
METHODS: Retrospective investigation of consecutive patients who underwent resection of ELSTs at our hospital between 1999 and 2019. The symptoms, diagnosis, surgical findings, and outcomes were analyzed to develop a tumor staging system and corresponding surgical strategy.
RESULTS: Retrospective review revealed the surgical treatment of 22 ELSTs. Based on intraoperative findings of tumor extent and size, ELSTs were classified into two types. Type-I (n = 6) referred to the small tumors that were locally confined with limited invasion of semicircular canals and dura; type-II (n = 16) referred to the large tumors that presented extensive erosion of at least one anatomic structure apart from the semicircular canals and the dura around endolymphatic sac. In this case series, Type-I ELST is amenable to resection through a transmastoidal approach, and subtotal petrosectomy is appropriate for the resection of type-II ELST. Sensorineural hearing loss (SNHL) is the most commonly preoperative symptom in both two types of cases. Five type-II ELSTs experienced recurrence and underwent reoperation, whereas all type-I ELSTs did not.
CONCLUSION: ELST usually results in SNHL (95%) at the time of diagnosis. The surgical strategy and prognosis of ELST resections are different between type-I and type-II: type-I ELST is amenable to transmastoidal approach with the preservation of facial nerve, whereas type-II ELST increase the surgical difficulty and the risk of recurrence, and subtotal petrosectomy is the basic requirement for the resection of type-II ELST.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Bleeding control; Endolymphatic sac tumor; Function preservation; Surgical strategy

Year:  2022        PMID: 35739425     DOI: 10.1007/s00405-022-07447-y

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  2 in total

1.  Surgical management of endolymphatic sac tumors.

Authors:  Rick A Friedman; Michael Hoa; Derald E Brackmann
Journal:  J Neurol Surg B Skull Base       Date:  2012-11-09

Review 2.  Von Hippel-Lindau disease.

Authors:  Prashant Chittiboina; Russell R Lonser
Journal:  Handb Clin Neurol       Date:  2015
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.